Table 4 Tumor recurrence details of the study patients
From: Actual long-term survival after resection of stage III soft tissue sarcoma
Long-term survivors (n = 7) | Short-term survivors (n = 36) | P-value | |
|---|---|---|---|
Recurrence timing | 0.009 | ||
< 1 year | 1 (14.3%) | 24 (66.7%) | |
1-2 years | 2 (28.6%) | 7 (19.4%) | |
2-5 years | 3 (42.9%) | 5 (13.9%) | |
> 5 years | 1 (14.3%) | 0 (0.0%) | |
Recurrence location | 0.04 | ||
Regional | 5 (71.4%) | 11 (30.6%) | |
Metastatic | 2 (28.6%) | 25 (69.4%) | |
Recurrence treatment | < 0.001 | ||
Resection | 3 (42.9%) | 5 (13.9%) | |
Resection + chemo/radiation | 4 (57.1%) | 4 (11.1%) | |
Chemo/radiation only | 0 (0.0%) | 10 (27.8%) | |
Supportive only | 0 (0.0%) | 17 (47.2%) |